Skip to content
Screener

Aprea Therapeutics, Inc. APRE Q4 2025 Annual earnings

Reported March 16, 2026 · Before market open

Revenue$3.3KIn line
EPS-$0.32Beat by $0.06
Revenue estimate$3.3K
EPS estimate-$0.38

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$307.5K
EPS estimate-$0.08

FAQ

When did Aprea Therapeutics, Inc. report Q4 2025 earnings?
Aprea Therapeutics, Inc. (APRE) reported Q4 2025 earnings on March 16, 2026 before market open.
What were Aprea Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Aprea Therapeutics, Inc. reported revenue of $3.3K and eps of $-0.32 for Q4 2025.
Did Aprea Therapeutics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $3.3K by -. EPS beat the consensus estimate of $-0.38 by $0.06.
How did Aprea Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 98.4% from $205.8K a year earlier and eps grew 34.7% from $-0.49.
Where can I find Aprea Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-028046) and the 10-K periodic report (0001104659-26-028068) directly on SEC EDGAR. The filing index links above go to sec.gov.